Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Alogliptin/Metformin bulk supplier for pharma manufacturers

Alogliptin/Metformin Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 12.5mg+500mg / 12.5mg+850mg / 12.5mg+1000mg

Reference Brands: Kazano (USA), Vipdomet (EU)

Category: Diabetes

Alogliptin/Metformin is an oral medication for type 2 diabetes mellitus. It combines alogliptin, a DPP-4 inhibitor, and metformin, a biguanide, to help control blood sugar levels. The combination improves insulin response and reduces liver glucose production. Taken twice daily with meals, it is used when diet, exercise, or single-drug therapy is insufficient.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Alogliptin / Metformin Hydrochloride tablets are an oral antidiabetic combination used for the management of type 2 diabetes mellitus. This formulation combines alogliptin, a DPP-4 inhibitor that enhances incretin hormone activity to increase insulin release and decrease glucagon levels, with metformin, which reduces hepatic glucose production and improves insulin sensitivity. Together, they provide effective glycemic control by targeting multiple pathways involved in glucose regulation. These tablets are commonly prescribed when monotherapy is insufficient and are typically used alongside diet and exercise to achieve better long-term blood sugar management and reduce the risk of diabetes-related complications.

Alogliptin/Metformin — third party manufacturing & bulk supply

Alogliptin/Metformin is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Alogliptin/Metformin is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Alogliptin/Metformin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Alogliptin/Metformin →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Alogliptin / Metformin tablets are used to improve blood sugar control in adults with type 2 diabetes mellitus. This combination is prescribed when diet, exercise, or single-drug therapy is not sufficient to maintain proper glycemic control.

These tablets are made from alogliptin benzoate and metformin hydrochloride. Alogliptin is a DPP-4 inhibitor that increases incretin hormones to regulate insulin secretion, while metformin decreases hepatic glucose production and improves insulin sensitivity.

Common trade names include Kazano (USA), Vipdomet (EU/UK), and various generic brands available in India, LATAM, and other emerging markets.

The original product is developed and marketed by Takeda Pharmaceuticals. It is also manufactured by multiple pharmaceutical companies globally, including Sun Pharma, Cipla, Lupin, Dr. Reddy’s Laboratories, and other generic manufacturers.

The complete generic name is alogliptin benzoate and metformin hydrochloride.

Brand names include Kazano, Vipdomet, and various region-specific generic brands.

These tablets are manufactured globally in countries such as the USA, UK, EU nations, India, and LATAM regions by both innovator and generic pharmaceutical companies.

Related Products

Repaglinide

Strength:
0.5 mg, 1 mg, 2 mg

Form: Tablets

Reference Brands: Prandin (USA)

View Details
Pioglitazone Hydrochloride 150Mg Tablet

Strength:
15 mg, 30 mg, 45 mg

Form: Tablets

Reference Brands: Actos (USA)

View Details
Nateglinide

Strength:
60 mg, 120 mg, 180 mg

Form: Tablets

Reference Brands: Starlix (USA)

View Details
Miglitol

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Glyset (USA), Diastabol (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.